BROKERS CHOICE: SBILIFE, REC, COFORGE, SUNPHARMA, TORRENTPHARMA, NESTLE, SRF, ABAMC, CGPOWER, BAJAJFIN

AHMEDABAD, 25 JULY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

CLSA on SBI Life: Maintain Outperform on Company, raise target price at Rs 2180 (Positive)

MS on SBI Life: Maintain Overweight on Company, target price at Rs 2115 (Positive)

CLSA on REC: Maintain Outperform on Company, target price at Rs 525 (Positive)

GS on Syngene: Maintain Buy on Company, target price at Rs 775 (Positive)

Bernstein on Coforge: Maintain Outperform on Company, target price at Rs 2038 (Positive)

MS on Sun Pharma: Maintain Overweight on Company, target price at Rs 1960 (Positive)

Investec on Torrent Pharma: Upgrade to Buy on Company, raise target price at Rs 4100 (Neutral)

Macquarie on Nestle: Maintain Neutral on Company, cut target price at Rs 2250 (Neutral)

Jefferies on SRF: Maintain Underperform on Company, raise target price at Rs 2640 (Neutral)

Jefferies on Supreme Ind: Maintain Buy on Company, cut target price at Rs 5100 (Neutral)

Citi on ABAMC: Maintain Sell on Company, raise target price at Rs 820 (Neutral)

UBS on CG Power: Maintain Buy on Company, cut target price at Rs 890 (Neutral)

Jefferies on Bajaj Fin: Maintain Buy on Company, raise target price at Rs 1100 (Neutral)

UBS on Bajaj Fin: Maintain Sell on Company, target price at Rs 750 (Neutral)

Macquarie on Bajaj Fin: Maintain Underperform on Company, target price at Rs 800 (Neutral)

Bernstein on Bajaj Fin: Maintain Underperform on Company, cut target price at Rs 640 (Negative)

JP Morgan on Bajaj Fin: Downgrade to Neutral on Company, cut target price at Rs 970 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)